Healio

FDA takes steps to reduce animal testing requirements for monoclonal antibodies

Please provide your email address to receive an email when new articles are posted on . The FDA plans to reduce and potentially replace animal testing for developing monoclonal antibody therapies and ...

Webinar: Investigating Out-of-Specification (OOS) Test Results in the Laboratory; FDA Guidance and Latest Expectations

Opportunities exist in providing training and consulting services focused on compliant handling of out-of-specification (OOS) results in laboratories. Businesses can cater to global regulatory ...
The Hill

FDA to phase out some animal testing requirements, possibly replace them with AI models

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...
Seeking Alpha

Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) strongly supports the U.S. Food and Drug Administration’s (FDA) plan to reduce, refine or potentially replace current animal testing ...
Benzinga.com

Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements

Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing ...
AOL

FDA says it will phase out animal testing requirement for monoclonal antibodies and drugs

The US Food and Drug Administration says its animal testing requirements "will be reduced, refined, or potentially replaced using a range of approaches." - Andrew Harnik/AP The US Food and Drug ...